- 专利标题： METHODS OF TREATING SICKLE CELL DISORDER AND RELATED CONDITIONS
-
申请号： US18288244申请日： 2022-05-10
-
公开(公告)号： US20240207358A1公开(公告)日： 2024-06-27
- 发明人: LIPING XIAO , Marja HURLEY , Tannin SCHMIDT
- 申请人： University of Connecticut
- 申请人地址： US CT Farmington
- 专利权人： University of Connecticut
- 当前专利权人： University of Connecticut
- 当前专利权人地址： US CT Farmington
- 国际申请： PCT/US2022/028470 2022.05.10
- 进入国家日期： 2023-10-25
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; A61P7/06
摘要：
The present disclosure is directed to administration of native or recombinant human PRG4 (rhPRG4) as a means to treat sickle cell disease or other disorders in subjects in need of treatment thereof.
信息查询
IPC分类:
